What is Pipelinepharma?
Pipelinepharma operates as a B2B pharmaceutical licensing marketplace, facilitating connections between pharmaceutical companies for strategic deals. These transactions can encompass mergers and acquisitions, technology transfers, licensing agreements, or distribution partnerships. Founded in 2012 and headquartered in Vilnius County, Lithuania, Pipelinepharma aims to streamline the complex process of pharmaceutical deal-making, fostering innovation and market access within the industry.
How much funding has Pipelinepharma raised?
Pipelinepharma has raised a total of $1.5M across 1 funding round:
Angel/Seed
$1.5M
Angel/Seed (2021): $1.5M with participation from Practica Capital
Key Investors in Pipelinepharma
Practica Capital
Practica Capital is a venture capital firm focused on backing entrepreneurs through various stages of funding, including seed and series A investments. With over 132 million euros under management, the firm has made more than 70 investments across diverse sectors such as biotech, fintech, and e-commerce.
What's next for Pipelinepharma?
The substantial enterprise-level funding Pipelinepharma has attracted signals a strong growth phase, likely focused on scaling its marketplace operations, expanding its global reach, and enhancing its platform's technological capabilities. This strategic investment is expected to accelerate the company's mission to become a central hub for pharmaceutical collaborations and transactions, driving efficiency and new opportunities within the life sciences sector.
See full Pipelinepharma company page
